Literature DB >> 18937652

Alexithymia and dermatology: the state of the art.

Ria Willemsen1, Diane Roseeuw, Johan Vanderlinden.   

Abstract

BACKGROUND: Alexithymia is a personality trait characterized by difficulties in differentiating and describing feelings. Research indicates that alexithymia acts as a triggering factor for many medical and psychiatric disorders. The interest in alexithymia has increased considerably over the past decade. A state of the art review of recent research on alexithymia in medical and dermatological research is presented.
METHODS: We reviewed most relevant publications on alexithymia from the field of clinical research, psychology, psychosomatics, and psycho-neuro-endocrinology. Systematic searches on alexithymia in dermatology were undertaken using the Cochrane Library and PUBMed.
RESULTS: Interdisciplinary research, investigating alexithymia, is advancing rapidly into different fields of medicine. Alexithymia has been found to be associated with changes in sympathetic activity, immunity and brain activity. Some researchers link alexithymia with insecure parental attachment and adverse childhood experiences. Although research of alexithymia in dermatology is still scarce and reveals conflicting results, preliminary data show that alexithymia seems to be associated with alopecia areata, psoriasis, atopic dermatitis, vitiligo or chronic urticaria.
CONCLUSION: Present research findings on alexithymia in the field of dermatology suggest important implications for the treatment of some specific dermatological disorders. Besides treating comorbid psychological problems such as anxiety and depression, dermatologists should also be aware of alexithymia and its possible association with an underlying dermatologic disease.

Entities:  

Mesh:

Year:  2008        PMID: 18937652     DOI: 10.1111/j.1365-4632.2008.03726.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  18 in total

1.  Alexithymia in Patients with Ménière Disease: A Possible Role on Anxiety and Depression.

Authors:  Roberto Teggi; Claudia Yvonne Finocchiaro; Claudio Ruggieri; Omar Gatti; Federica Rosolen; Mario Bussi; Lucio Sarno
Journal:  Audiol Res       Date:  2021-02-23

Review 2.  [Dermatological diseases and their importance for psychiatry].

Authors:  P Mavrogiorgou; G Juckel
Journal:  Nervenarzt       Date:  2017-03       Impact factor: 1.214

Review 3.  Current concepts in psychodermatology.

Authors:  Joseph A Locala
Journal:  Curr Psychiatry Rep       Date:  2009-06       Impact factor: 5.285

4.  Alexithymia and acne vulgaris: a case control study.

Authors:  Didem Sunay; Murat Baykir; Gülfem Ateş; Meral Ekşioğlu
Journal:  Psychiatry Investig       Date:  2011-11-03       Impact factor: 2.505

5.  Psychological interventions in the management of common skin conditions.

Authors:  Philip D Shenefelt
Journal:  Psychol Res Behav Manag       Date:  2010-03-26

6.  Alexithymia, anxiety and depression in patients with psoriasis: a case-control study.

Authors:  Panagiota Korkoliakou; Christos Christodoulou; Anargyros Kouris; Evgenia Porichi; Vasiliki Efstathiou; Eythymia Kaloudi; Anna Kokkevi; Nikolaos Stavrianeas; Charalabos Papageorgiou; Athanasios Douzenis
Journal:  Ann Gen Psychiatry       Date:  2014-12-10       Impact factor: 3.455

Review 7.  A review of psychiatric disorders comorbidities in patients with alopecia areata.

Authors:  Ahmad Ghanizadeh; Anaheed Ayoobzadehshirazi
Journal:  Int J Trichology       Date:  2014-01

8.  Alexithymia in Gastroenterology and Hepatology: A Systematic Review.

Authors:  Danilo Carrozzino; Piero Porcelli
Journal:  Front Psychol       Date:  2018-04-06

9.  Emotional intelligence as an indicator of satisfaction with life of patients with psoriasis.

Authors:  Małgorzata A Basińska; Marta Drozdowska
Journal:  Postepy Dermatol Alergol       Date:  2013-12-18       Impact factor: 1.837

10.  Sense of alexithymia in patients with anxiety disorders comorbid with recurrent urticaria.

Authors:  Ewa A Ogłodek; Anna M Szota; Marek J Just; Aleksander Araszkiewicz; Adam R Szromek
Journal:  Neuropsychiatr Dis Treat       Date:  2016-04-21       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.